Article
Inhibition of the Bcl-x <sub>L</sub> Deamidation Pathway in Myeloproliferative Disorders
24 Dec 2008
Abstract excerpt
BACKGROUND: The myeloproliferative disorders are clonal disorders with frequent somatic gain-of-function alterations affecting tyrosine kinases. In these diseases, there is an increase in DNA damage and a risk of progression to acute leukemia. The molecular mechanisms in myeloproliferative disorders that prevent apoptosis induced by damaged DNA are obscure. METHODS: We searched for abnormalities of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
